|
|
| Intensified Chromatography Strategies | | The blockbuster drug era is over, and drug manufacturers are now striving for a more diversified portfolio. With a newer toolbox of options to intensify downstream manufacturing operations, it is important to understand what factors should impact decisions regarding the implementation of these solutions. |
|
|
|
|
Although single-use technologies are widely adopted in upstream production processes, what is necessary to transition them to downstream manufacturing scale? Explore strategies for meeting the ever-increasing upstream titers and volumes to prevent purification from becoming a bottleneck. |
|
|
|
|
|
|
|
|
|
|
|
|
